e-Learning | Management of Polycythaemia Vera

6th June 2019 by Louise Hudman

e-Learning | Management of Polycythaemia Vera

This is an updated guideline on the diagnosis and management of polycythaemia vera (PV) from the British Society for Haematology. It was published in Nov 18. PV is the same as polycythaemia rubra vera and PCV.

Much of this is beyond what we need, but it outlines how we should be approaching a patient with raised haematocrit, which is useful.

If (like me) your understanding of PV is a bit sketchy, then patient.co.uk has a good reminder. In short, PV is a clonal haematological malignancy. It is caused by a mutation in a single haematopoietic stem cell. The JAK2 gene is mutated in nearly all PV.

What should trigger us to investigate further?

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

Related content

"I’m loving LocumDeck, it’s a great piece of software."

Dr David Williams

Dr David Williams

See the full list of features within our NASGP membership plans

Membership